跳至主要内容
临床试验/NL-OMON39086
NL-OMON39086已完成不适用

Effects of growth hormone treatment after final height in Prader-Willi Syndrome: A double-blind multicenter, cross-over study on the effects of growth hormone versus placebo on body composition and psychosocial behaviour in transition - Effects of GH after final height in PWS

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 26 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • genetically confirmed diagnosis of Prader-Willi syndrome
  • treated with GH for at least 2 years
  • final height is reached or epiphysial fusion is complete
  • aged 18-24 years

排除标准

  • non-cooperative behaviour
  • extremely low dietary intake of less than minimal required intake according to WHO
  • medication to reduce weight (fat)

研究者

相似试验